Search results for “Cns disease” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 1,224 patents, we discovered top 201 key players by total patent application. F. Hoffmann-La Roche Ltd., Pfizer Inc., Novartis AG are dominant in this area. They take 16.75% of the total patent filing.
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 127
Pfizer Inc.
New York, United States
Patent: 43
Novartis AG
Basel-Stadt, Switzerland
Patent: 35
H. Lundbeck A/S
Hovedstaden, Denmark
Patent: 35
Pharmacia & Upjohn Co. LLC
Michigan, United States
Patent: 34
Bayer AG
Nordrhein-Westfalen, Germany
Patent: 30
Sunovion Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 27
Ranbaxy Laboratories Ltd.
Haryana, India
Patent: 25
Dart NeuroScience LLC
California, United States
Patent: 25
Ramot at Tel Aviv University Ltd.
Israel
Patent: 24
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 24 patents, we discovered top 6 start-ups by total patent application. Prevail Therapeutics, Inc., Blue Oak Pharmaceuticals, Inc., XWPharma Ltd. are active in this area.
STARTUP
Prevail Therapeutics, Inc.
New York, United States
Patent: 8
STARTUP
Blue Oak Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 5
STARTUP
XWPharma Ltd.
Hubei Sheng, China
Patent: 4
STARTUP
Affinia Therapeutics, Inc.
Massachusetts, United States
Patent: 3
STARTUP
Holobiome, Inc.
Massachusetts, United States
Patent: 3
STARTUP
Autobahn Therapeutics, Inc.
California, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 248 patents applied in the last 5 years. We discover 71 most active companies in this area. The fast-growing F. Hoffmann-La Roche Ltd., Alar Pharmaceuticals, Inc., German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) take 17.34% of patent filing during this period.
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 18
Alar Pharmaceuticals, Inc.
Taiwan Province, China
Patent: 16
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
Germany
Patent: 9
Vcell Therapeutics Inc
United States
Patent: 8
STARTUP
Prevail Therapeutics, Inc.
New York, United States
Patent: 8
Regents of the University of California
California, United States
Patent: 7
Intra-Cellular Therapies, Inc.
New York, United States
Patent: 6
Brii Biosciences, Inc.
North Carolina, United States
Patent: 6
AgeneBio, Inc.
Indiana, United States
Patent: 6
Translate Bio, Inc.
Massachusetts, United States
Patent: 5
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 248 patents in last 5 years, we discover 47 new entrants. Alar Pharmaceuticals, Inc., Prevail Therapeutics, Inc., Vcell Therapeutics Inc are the most active new entrants in this area.
Alar Pharmaceuticals, Inc.
Taiwan Province, China
Patent: 16
STARTUP
Prevail Therapeutics, Inc.
New York, United States
Patent: 8
Vcell Therapeutics Inc
United States
Patent: 8
Brii Biosciences, Inc.
North Carolina, United States
Patent: 6
AgeneBio, Inc.
Indiana, United States
Patent: 6
Akroswiss AG
Zug, Switzerland
Patent: 5
University of Copenhagen
Hovedstaden, Denmark
Patent: 5
STARTUP
Blue Oak Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 5
Creative Bio-Peptides, Inc.
United States
Patent: 4
NeuraMetrix, Inc.
California, United States
Patent: 4
Research Institutions
Order by:
Innovation Intensity
With the analysis among 106 patents, we discovered top 28 universities and scientific research institutions by total patent application. University of Copenhagen, Yale University, The Johns Hopkins University are dominant in this area. They take 22.64% of the total patent filing.
University of Copenhagen
Hovedstaden, Denmark
Patent: 5
Yale University
Connecticut, United States
Patent: 4
The Johns Hopkins University
United States
Patent: 4
Washington University in St. Louis
Missouri, United States
Patent: 4
University of Miami
United States
Patent: 3
The University of Montana
Montana, United States
Patent: 3
University of Basel
Basel-Stadt, Switzerland
Patent: 3
University of Tokushima
Tokushima-ken, Japan
Patent: 3
University of Bern
Bern, Switzerland
Patent: 3
University of Zurich
ZURICH, Switzerland
Patent: 3
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: